These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma. Complementary statement from the International Mesothelioma Interest Group, also endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology. Hjerpe A, Ascoli V, Bedrossian CWM, Boon ME, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P. Acta Cytol; 2015; 59(1):2-16. PubMed ID: 25824655 [Abstract] [Full Text] [Related]
3. Guidelines for the cytopathologic diagnosis of epithelioid and mixed-type malignant mesothelioma: Complementary Statement from the International Mesothelioma Interest Group, Also Endorsed by the International Academy of Cytology and the Papanicolaou Society of Cytopathology. Hjerpe A, Ascoli V, Bedrossian CW, Boon ME, Creaney J, Davidson B, Dejmek A, Dobra K, Fassina A, Field A, Firat P, Kamei T, Kobayashi T, Michael CW, Önder S, Segal A, Vielh P, International Mesothelioma Interest Group, International Academy of Cytology. Diagn Cytopathol; 2015 Jul; 43(7):563-76. PubMed ID: 26100969 [Abstract] [Full Text] [Related]
10. Role of Cytology in the Current Guidelines for Malignant Mesothelioma: Largest Study from India. Kaur K, Patel T, Samanta S, Patra S, Trivedi P. Acta Cytol; 2021 Jul; 65(2):175-185. PubMed ID: 33316798 [Abstract] [Full Text] [Related]
12. The Papanicolaou Society of Cytopathology classification for pulmonary specimens: an overview. Layfield LJ. Cytopathology; 2016 Jun; 27(3):149-52. PubMed ID: 27221749 [Abstract] [Full Text] [Related]
13. Effusion cytology of malignant mesothelioma enables earlier diagnosis and recognizes patients with better prognosis. Abd Own S, Höijer J, Hillerdahl G, Dobra K, Hjerpe A. Diagn Cytopathol; 2021 May; 49(5):606-614. PubMed ID: 32049443 [Abstract] [Full Text] [Related]
16. The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis. Klebe S, Nakatani Y, Dobra K, Butnor KJ, Roden AC, Nicholson AG, Marchevsky AM, Husain AN, Segal A, Walts AE, Weynand B, Michael CW, Dacic S, Godbolt D, Attanoos R, Santoni-Rugiu E, Galateau-Salle F, Hiroshima K, Moreira AL, Burn J, Nabeshima K, Gibbs AR, Churg A, Litzky LA, Brcic L, Tsao MS, Mino-Kenudson M, Rørvig SB, Tazelaar HD, Krausz T, Zhang YZ, Chirieac LR, Beasley MB, Hjerpe A. Pathology; 2021 Jun; 53(4):446-453. PubMed ID: 33775406 [Abstract] [Full Text] [Related]
17. Review of the impact of the International System for Serous Fluid Cytopathology. Mikou P, Pergaris A, Engels M, Chandra A. Cytopathology; 2024 Jan; 35(1):16-22. PubMed ID: 37795809 [Abstract] [Full Text] [Related]
19. Evolution of guidelines for respiratory cytology by the Papanicolaou Society of Cytopathology. Moreira AL. Diagn Cytopathol; 2020 Oct; 48(10):867-869. PubMed ID: 32359109 [Abstract] [Full Text] [Related]
20. Diagnostic value of BRCA1-associated protein-1, glucose transporter-1 and desmin expression in the discrimination between reactive mesothelial proliferation and malignant mesothelioma in tissues and effusions. Önder S, Özogul E, Koksal D, Sarinc Ulasli S, Firat P, Emri S. Cytopathology; 2019 Nov; 30(6):592-600. PubMed ID: 31165505 [Abstract] [Full Text] [Related] Page: [Next] [New Search]